# Rockwell Automation and Industry Leaders Launch the Digital CMC Consortium to Accelerate Digital Transformation in Pharmaceutical Development

- Link: https://www.thailand-business-news.com/pr-news/rockwell-automation-and-industry-leaders-launch-the-digital-cmc-consortium-to-accelerate-digital-transformation-in-pharmaceutical-development
- Published: 2026-10-08T20:00:00+07:00
- Author: PR Newswire

|   |

_New industry collaboration addresses pharma’s most complex development challenges
and expedites patient access to breakthrough therapies_

MILWAUKEE, Oct. 8, 2026 /PRNewswire/ — [Rockwell Automation, Inc.](https://www.rockwellautomation.com/en-us.html?utm_source=ThirdParty&utm_medium=Public_Relations&utm_campaign=701Pg00002XxraXIAR&utm_content=LSBOILERUS)(
NYSE: ROK), the world’s largest company dedicated to industrial automation and digital
transformation, today announced it is a founding member of the [Digital CMC Consortium](https://www.digitalcmc.org/),
a not-for-profit, pre-competitive industry collaboration focused on advancing digital
standards and infrastructure to accelerate drug development.

[⌊Rockwell Automation and Industry Leaders Launch the Digital CMC Consortium to 
Accelerate Digital Transformation in Pharmaceutical Development⌉⌊Rockwell Automation
and Industry Leaders Launch the Digital CMC Consortium to Accelerate Digital Transformation
in Pharmaceutical Development⌉[
Rockwell Automation and Industry Leaders Launch 
the Digital CMC Consortium to Accelerate Digital Transformation in Pharmaceutical
Development

Pharmaceutical companies face growing pressure to accelerate development timelines
and manage rising costs while meeting complex regulatory requirements. Yet Chemistry,
Manufacturing and Controls (CMC) activities, which define how a drug is developed,
manufactured, tested and controlled to ensure quality, remain a longstanding bottleneck
in drug development due to manual, document-based workflows and a lack of process
standardization. As therapies become more complex and personalized, CMC activities
must evolve into structured, digital systems that accelerate technology transfer
and enable seamless knowledge sharing and data-driven decision-making.

The Consortium brings together industry leaders across the CMC ecosystem — pharmaceutical
organizations, biotechnology firms, contract development and manufacturing organizations(
CDMOs), technology providers and consulting experts — to address these shared challenges
through a coordinated, outcomes-focused approach. Founded by visionary leaders from
companies such as Rockwell Automation, Novartis, Thermo Fisher Scientific, Takeda,
Flagship’s Pioneering Medicines, Stellix, ZS Associates and QbDVision, the Consortium
harnesses collective expertise to solve industry-wide challenges no organization
could tackle independently.

"Digital transformation in life sciences is not just about technology adoption, 
it is about building new ways of working that improve how therapies are developed
and delivered," said Matt Weaver, vice president, global industry – life sciences,
Rockwell Automation. "The Consortium reflects the partnership-driven approach needed
to advance the pharma industry. With deep life sciences expertise and experience
supporting both pharma innovators and the CDMOs, we are proud to work alongside 
fellow founding members to help shape the future of pharmaceutical manufacturing
and CMC digitization, connecting development, manufacturing and commercialization
across product lifecycle."

Following its first year of collaboration and proof-of-concept work, the Consortium
is advancing toward broader industry adoption. Its immediate focus includes digital
technology transfer and structured knowledge exchange between sponsors and CDMOs.
Longer term, the Consortium aims to connect digital capabilities across the full
CMC lifecycle, including knowledge management, automated content authoring, digital
twins and artificial intelligence.

To learn more about the Digital CMC Consortium and how to get involved, visit [www.digitalcmc.org](https://www.digitalcmc.org/).

**About Rockwell Automation**
Rockwell Automation, Inc. (NYSE: [ROK](https://www.rockwellautomation.com/en-us.html?utm_source=ThirdParty&utm_medium=Public_Relations&utm_campaign=701Pg00002XxraXIAR&utm_content=LSBOILERUS)),
is a global leader in industrial automation and digital transformation. We connect
the imaginations of people with the potential of technology to expand what is humanly
possible, making the world more productive and more sustainable. Headquartered in
Milwaukee, Wisconsin, Rockwell Automation employs approximately 26,000 problem solvers
dedicated to our customers in more than 100 countries as of fiscal year end 2025.
To learn more about how we are bringing the Connected Enterprise® to life across
industrial enterprises, visit [www.rockwellautomation.com](https://www.rockwellautomation.com/en-us.html?utm_source=ThirdParty&utm_medium=Public_Relations&utm_campaign=701Pg00002XxraXIAR&utm_content=LSBOILERUS).

**About the Digital CMC ConsortiumThe Digital CMC Consortium is a pre-competitive
not-for-profit industry collaboration organized around a singular goal: the end-
to-end digitalization of Chemistry, Manufacturing, and Controls (CMC). The Consortium
unites pharmaceutical organizations, CDMOs, consulting firms, and technology innovators
to establish open digital standards across drug development and manufacturing, laying
the foundation for the AI era in CMC. Upgrading this legacy infrastructure removes
a major bottleneck, accelerating the delivery of life-saving therapies to the patients
who need them urgently. Learn more at [https://www.digitalcmc.org](https://www.digitalcmc.org/).

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Rockwell Automation and Industry Leaders Launch the Digital CMC Consortium to Accelerate Digital Transformation in Pharmaceutical Development ](http://www.prnasia.com/story/archive/5066142_AE66142_0?rand=184833)
